Xinhua Biology (信华生物)
Guang Zhou Shi, China
Xinhua Biotech is a leading AI-driven macromolecule drug research and development company, founded in 2019 by a team of senior antibody drug engineering and computational scientists. The company has extensive experience in macromolecule drug research and development along with unique advantages in engineering development data. Its innovative target discovery platform and advanced algorithm platform for antibody structure and engineering have led to significant technological breakthroughs. Currently, the company is focused on addressing unmet medical needs, particularly in tumor immunotherapy, with multiple projects that have demonstrated positive biological verification data.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- www.vibrantx.net
Only accessible to MedStartr community members.
Join nowWhat do you think of Xinhua Biology (信华生物)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now